Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for VCYT
| Stock Name | Veracyte Inc |
| Ticker | VCYT(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US92337F1075 |
| LEI | 529900ESWZRHXOW27Z37 |
Show aggregate VCYT holdings
News associated with VCYT
- 1,616 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Headlands Technologies LLC
- Headlands Technologies LLC purchased a new position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,616 shares of the biotechnology company’s stock, valued at approximately $48,000. Several other large investors have also […] - 2025-08-13 05:22:59
- Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Recommendation of “Moderate Buy” by Brokerages
- Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating on […] - 2025-08-12 02:44:59
- Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
- Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 12.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,368 shares of the biotechnology company’s stock after purchasing an additional 3,201 shares during the […] - 2025-08-06 04:52:59
- Veracyte (NASDAQ:VCYT) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.
- Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Veracyte, Inc. (NASDAQ:VCYT). In a filing disclosed on July 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Veracyte stock on June 16th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account. Representative Gilbert Ray […] - 2025-07-28 03:00:42
- Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Bank Julius Baer & Co. Ltd Zurich
- Bank Julius Baer & Co. Ltd Zurich reduced its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 9.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,905 shares of the biotechnology company’s stock after selling 2,059 shares during the period. […] - 2025-07-25 06:31:01
- Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) Price Target at $40.90
- Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eight have assigned a buy rating to […] - 2025-07-21 02:14:56
- Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Teacher Retirement System of Texas
- Teacher Retirement System of Texas lowered its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 49.3% during the first quarter, HoldingsChannel reports. The institutional investor owned 33,938 shares of the biotechnology company’s stock after selling 33,036 shares during the quarter. Teacher Retirement System of Texas’ holdings in Veracyte were worth $1,006,000 at the end […] - 2025-07-14 04:50:48
- Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Diversified Trust Co
- Diversified Trust Co lowered its stake in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 48.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,840 shares of the biotechnology company’s stock after selling 8,209 shares during the quarter. Diversified Trust Co’s holdings […] - 2025-07-02 05:18:56
- Veracyte, Inc. (NASDAQ:VCYT) Receives $40.90 Average Target Price from Analysts
- Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and eight have assigned a buy recommendation to the […] - 2025-06-26 02:23:05
- Exchange Traded Concepts LLC Increases Stake in Veracyte, Inc. (NASDAQ:VCYT)
- Exchange Traded Concepts LLC boosted its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 32.5% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 91,994 shares of the biotechnology company’s stock after buying an additional 22,565 shares during the period. Exchange Traded Concepts LLC owned approximately 0.12% […] - 2025-06-17 05:36:53
- Rhumbline Advisers Sells 2,870 Shares of Veracyte, Inc. (NASDAQ:VCYT)
- Rhumbline Advisers cut its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 120,454 shares of the biotechnology company’s stock after selling 2,870 shares during the period. Rhumbline Advisers’ holdings in Veracyte were worth $3,571,000 as […] - 2025-06-15 06:08:55
- California State Teachers Retirement System Sells 510 Shares of Veracyte, Inc. (NASDAQ:VCYT)
- California State Teachers Retirement System lowered its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,834 shares of the biotechnology company’s stock after selling 510 shares during the […] - 2025-06-06 06:02:58
- Janus Henderson Group PLC Acquires 4,000 Shares of Veracyte, Inc. (NASDAQ:VCYT)
- Janus Henderson Group PLC raised its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 13.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,326 shares of the biotechnology company’s stock after acquiring an additional 4,000 shares during the quarter. Janus Henderson […] - 2025-05-23 05:27:01
- Deutsche Bank AG Purchases 24,197 Shares of Veracyte, Inc. (NASDAQ:VCYT)
- Deutsche Bank AG grew its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 42.4% in the fourth quarter, Holdings Channel reports. The fund owned 81,266 shares of the biotechnology company’s stock after acquiring an additional 24,197 shares during the quarter. Deutsche Bank AG’s holdings in Veracyte were worth $3,218,000 at the end of the […] - 2025-05-21 04:42:57
- The Manufacturers Life Insurance Company Sells 1,731 Shares of Veracyte, Inc. (NASDAQ:VCYT)
- The Manufacturers Life Insurance Company lessened its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 4.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,186 shares of the biotechnology company’s stock after selling 1,731 shares during the quarter. The Manufacturers Life Insurance Company […] - 2025-05-12 04:43:01
- Tudor Investment Corp ET AL Sells 20,531 Shares of Veracyte, Inc. (NASDAQ:VCYT)
- Tudor Investment Corp ET AL lessened its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 50.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,342 shares of the biotechnology company’s stock after selling 20,531 shares during the quarter. […] - 2025-05-08 06:44:55
- Veracyte, Inc. (NASDAQ:VCYT) Shares Bought by Hsbc Holdings PLC
- Hsbc Holdings PLC grew its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 14.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,084 shares of the biotechnology company’s stock after acquiring an additional 1,406 shares during the quarter. Hsbc Holdings PLC’s holdings […] - 2025-05-08 06:07:00
- Price T Rowe Associates Inc. MD Has $1.92 Million Holdings in Veracyte, Inc. (NASDAQ:VCYT)
- Price T Rowe Associates Inc. MD raised its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 3.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 48,414 shares of the biotechnology company’s stock after acquiring an additional 1,816 shares during the quarter. […] - 2025-05-08 04:58:52
- Voya Investment Management LLC Decreases Position in Veracyte, Inc. (NASDAQ:VCYT)
- Voya Investment Management LLC decreased its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,066 shares of the biotechnology company’s stock after selling 1,781 shares during the period. Voya Investment Management […] - 2025-05-07 05:58:57
- Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) PT at $42.60
- Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eight have assigned a buy recommendation to the […] - 2025-05-07 02:19:08
- Veracyte, Inc. (NASDAQ:VCYT) Short Interest Up 22.5% in April
- Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 5,110,000 shares, a growth of 22.5% from the March 31st total of 4,170,000 shares. Based on an average daily volume of 956,000 shares, the short-interest ratio is […] - 2025-05-05 02:36:53
- First Trust Advisors LP Has $8.08 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)
- First Trust Advisors LP boosted its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 155.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 204,042 shares of the biotechnology company’s stock after acquiring an additional 124,275 shares during the quarter. First Trust Advisors […] - 2025-04-30 05:52:59
- Russell Investments Group Ltd. Has $2.60 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)
- Russell Investments Group Ltd. increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 233.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,541 shares of the biotechnology company’s stock after purchasing an additional 45,876 shares during the quarter. […] - 2025-04-18 04:53:09
- Veracyte, Inc. (NASDAQ:VCYT) Shares Bought by Alliancebernstein L.P.
- Alliancebernstein L.P. grew its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 98,420 shares of the biotechnology company’s stock after purchasing an additional 2,000 shares during the period. Alliancebernstein L.P. owned […] - 2025-04-15 04:52:54
- Veracyte (NASDAQ:VCYT) Given New $37.00 Price Target at Guggenheim
- Veracyte (NASDAQ:VCYT – Get Free Report) had its price objective cut by stock analysts at Guggenheim from $45.00 to $37.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective points to a potential upside of 22.31% from the stock’s current price. […] - 2025-04-11 04:46:55
- Veracyte (NASDAQ:VCYT) Shares Gap Down After Analyst Downgrade
- Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) gapped down before the market opened on Wednesday after Guggenheim lowered their price target on the stock from $45.00 to $37.00. The stock had previously closed at $28.88, but opened at $27.22. Guggenheim currently has a buy rating on the stock. Veracyte shares last traded at […] - 2025-04-10 02:40:48
- Norges Bank Takes $8.93 Million Position in Veracyte, Inc. (NASDAQ:VCYT)
- Norges Bank acquired a new position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) in the fourth quarter, Holdings Channel reports. The firm acquired 225,602 shares of the biotechnology company’s stock, valued at approximately $8,934,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in VCYT. […] - 2025-04-09 04:56:52
- Veracyte, Inc. (NASDAQ:VCYT) Shares Acquired by Vanguard Group Inc.
- Vanguard Group Inc. increased its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 6.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 8,211,612 shares of the biotechnology company’s stock after buying an additional 463,098 shares during the quarter. Vanguard Group Inc. owned about 0.11% of Veracyte worth $325,180,000 as of its most […] - 2025-04-04 05:04:58
- Corebridge Financial Inc. Lowers Stake in Veracyte, Inc. (NASDAQ:VCYT)
- Corebridge Financial Inc. decreased its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 7.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 38,204 shares of the biotechnology company’s stock after selling 2,885 shares during the quarter. Corebridge Financial Inc.’s holdings in Veracyte were worth $1,513,000 at the end of the […] - 2025-04-03 05:49:01
- Prudential Financial Inc. Has $4.83 Million Stake in Veracyte, Inc. (NASDAQ:VCYT)
- Prudential Financial Inc. raised its position in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 602.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,003 shares of the biotechnology company’s stock after acquiring an additional 104,639 shares during the period. […] - 2025-04-01 05:32:46
iShares MSCI World Small Cap UCITS ETF USD (Acc) VCYT holdings
| Date | Number of VCYT Shares Held | Base Market Value of VCYT Shares | Local Market Value of VCYT Shares | Change in VCYT Shares Held | Change in VCYT Base Value | Current Price per VCYT Share Held | Previous Price per VCYT Share Held |
|---|
| 2025-10-15 (Wednesday) | 56,265 | USD 1,956,897 | USD 1,956,897 | | | | |
| 2025-10-10 (Friday) | 55,923 | USD 1,946,120 | USD 1,946,120 | | | | |
| 2025-10-08 (Wednesday) | 55,923 | USD 1,962,897 | USD 1,962,897 | | | | |
| 2025-10-07 (Tuesday) | 55,923 | USD 1,935,495 | USD 1,935,495 | 228 | USD -71,753 | USD 34.61 | USD 36.04 |
| 2025-10-06 (Monday) | 55,695 | USD 2,007,248 | USD 2,007,248 | 0 | USD 2,228 | USD 36.04 | USD 36 |
| 2025-10-03 (Friday) | 55,695 | USD 2,005,020 | USD 2,005,020 | 0 | USD 20,607 | USD 36 | USD 35.63 |
| 2025-10-02 (Thursday) | 55,695 | USD 1,984,413 | USD 1,984,413 | 0 | USD -32,303 | USD 35.63 | USD 36.21 |
| 2025-10-01 (Wednesday) | 55,695 | USD 2,016,716 | USD 2,016,716 | 0 | USD 104,707 | USD 36.21 | USD 34.33 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of VCYT by Blackrock for IE00BF4RFH31
Show aggregate share trades of VCYT| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 228 | | | 34.610* | | 32.98 |
| 2025-09-08 | SELL | -456 | | | 32.460* | | 32.91 Profit of 15,005 on sale |
| 2025-08-15 | BUY | 228 | | | 30.220* | | 32.92 |
| 2025-08-07 | BUY | 684 | | | 27.680* | | 32.97 |
| 2025-07-29 | BUY | 228 | | | 24.470* | | 33.30 |
| 2025-07-14 | BUY | 460 | | | 26.650* | | 33.69 |
| 2025-06-30 | BUY | 460 | | | 27.030* | | 34.00 |
| 2025-06-25 | BUY | 690 | | | 26.450* | | 34.15 |
| 2025-06-20 | SELL | -115 | | | 26.390* | | 34.31 Profit of 3,946 on sale |
| 2025-06-12 | SELL | -920 | | | 26.690* | | 34.65 Profit of 31,881 on sale |
| 2025-06-02 | BUY | 348 | | | 26.740* | | 35.12 |
| 2025-05-28 | BUY | 230 | | | 26.720* | | 35.32 |
| 2025-05-14 | BUY | 114 | | | 28.490* | | 35.96 |
| 2025-05-13 | BUY | 228 | | | 29.310* | | 36.02 |
| 2025-05-07 | BUY | 345 | | | 30.840* | | 36.22 |
| 2025-04-28 | BUY | 114 | | | 31.670* | | 36.59 |
| 2025-04-16 | BUY | 1,482 | | | 31.530* | | 37.04 |
| 2025-04-14 | BUY | 228 | | | 32.140* | | 37.15 |
| 2025-04-08 | SELL | -230 | | | 28.880* | | 37.44 Profit of 8,611 on sale |
| 2025-04-04 | SELL | -232 | | | 28.950* | | 37.63 Profit of 8,731 on sale |
| 2025-03-28 | BUY | 1,150 | | | 30.120* | | 38.02 |
| 2025-03-12 | SELL | -230 | | | 30.960* | | 39.12 Profit of 8,998 on sale |
| 2025-03-04 | SELL | -230 | | | 34.110* | | 39.67 Profit of 9,124 on sale |
| 2025-02-28 | SELL | -5,522 | | | 34.760* | | 39.85 Profit of 220,040 on sale |
| 2025-02-26 | SELL | -508 | | | 35.530* | | 40.02 Profit of 20,330 on sale |
| 2025-02-13 | BUY | 127 | | | 39.590* | | 40.07 |
| 2025-02-12 | BUY | 508 | | | 40.380* | | 40.07 |
| 2025-01-27 | BUY | 126 | | | 42.930* | | 38.92 |
| 2025-01-23 | BUY | 126 | | | 44.070* | | 38.64 |
| 2024-12-09 | BUY | 4,572 | | | 42.760* | | 38.10 |
| 2024-12-04 | BUY | 254 | | | 44.090* | | 37.52 |
| 2024-12-03 | BUY | 381 | | | 43.660* | | 37.30 |
| 2024-11-19 | BUY | 768 | | | 39.150* | | 35.04 |
| 2024-11-18 | BUY | 256 | | | 36.710* | | 34.94 |
| 2024-11-12 | BUY | 508 | | | 38.240* | | 34.73 |
| 2024-11-11 | BUY | 127 | | | 38.890* | | 34.46 |
| 2024-11-07 | BUY | 635 | | | 37.340* | | 34.08 |
| 2024-10-23 | BUY | 254 | | | 32.450* | | 32.86 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of VCYT
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 402,884 | 350 | 744,518 | 54.1% |
| 2025-09-18 | 133,694 | 0 | 302,246 | 44.2% |
| 2025-09-17 | 102,785 | 125 | 273,625 | 37.6% |
| 2025-09-16 | 87,040 | 0 | 147,745 | 58.9% |
| 2025-09-15 | 132,517 | 56 | 260,101 | 50.9% |
| 2025-09-12 | 104,528 | 0 | 208,625 | 50.1% |
| 2025-09-11 | 145,462 | 0 | 339,206 | 42.9% |
| 2025-09-10 | 375,703 | 0 | 425,984 | 88.2% |
| 2025-09-09 | 166,026 | 0 | 264,898 | 62.7% |
| 2025-09-08 | 308,588 | 0 | 416,299 | 74.1% |
| 2025-09-05 | 304,507 | 10,500 | 433,106 | 70.3% |
| 2025-09-04 | 285,198 | 9,691 | 351,707 | 81.1% |
| 2025-09-03 | 290,774 | 0 | 410,275 | 70.9% |
| 2025-09-02 | 242,677 | 328 | 272,947 | 88.9% |
| 2025-08-29 | 221,159 | 98 | 280,820 | 78.8% |
| 2025-08-28 | 175,074 | 2 | 379,194 | 46.2% |
| 2025-08-27 | 232,979 | 0 | 412,237 | 56.5% |
| 2025-08-26 | 109,763 | 0 | 254,603 | 43.1% |
| 2025-08-25 | 126,935 | 150 | 195,395 | 65.0% |
| 2025-08-22 | 178,073 | 0 | 354,773 | 50.2% |
| 2025-08-21 | 181,726 | 8,870 | 254,596 | 71.4% |
| 2025-08-20 | 138,840 | 313 | 198,829 | 69.8% |
| 2025-08-19 | 153,214 | 124 | 248,803 | 61.6% |
| 2025-08-18 | 106,906 | 2,453 | 169,688 | 63.0% |
| 2025-08-15 | 178,920 | 3,513 | 228,774 | 78.2% |
| 2025-08-14 | 322,958 | 483 | 432,341 | 74.7% |
| 2025-08-13 | 669,266 | 26 | 854,665 | 78.3% |
| 2025-08-12 | 356,389 | 699 | 440,945 | 80.8% |
| 2025-08-11 | 355,148 | 650 | 511,010 | 69.5% |
| 2025-08-08 | 457,220 | 700 | 602,613 | 75.9% |
| 2025-08-07 | 583,576 | 120 | 1,202,651 | 48.5% |
| 2025-08-06 | 313,073 | 96 | 542,796 | 57.7% |
| 2025-08-05 | 399,687 | 16 | 494,592 | 80.8% |
| 2025-08-04 | 291,020 | 107 | 420,209 | 69.3% |
| 2025-08-01 | 239,653 | 10 | 322,446 | 74.3% |
| 2025-07-31 | 311,916 | 3,467 | 452,665 | 68.9% |
| 2025-07-30 | 406,408 | 1,200 | 573,800 | 70.8% |
| 2025-07-29 | 514,194 | 14 | 682,098 | 75.4% |
| 2025-07-28 | 1,469,060 | 160 | 2,707,100 | 54.3% |
| 2025-07-25 | 980,574 | 16,828 | 2,309,758 | 42.5% |
| 2025-07-24 | 70,902 | 139 | 182,759 | 38.8% |
| 2025-07-23 | 114,868 | 377 | 213,735 | 53.7% |
| 2025-07-22 | 131,718 | 134 | 372,351 | 35.4% |
| 2025-07-21 | 94,278 | 3,694 | 206,207 | 45.7% |
| 2025-07-18 | 151,324 | 1,062 | 447,377 | 33.8% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.